Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Thursday, July 21, 2011

High-Risk Groups Not Receiving Vaccinations Against Hep A, B

Most adults who have chronic liver disease or type 2 diabetes do not receive the recommended vaccinations against hepatitis A and B viruses (HAV and HBV), even though these groups are considered at high risk for severe liver injury if they are acutely infected, said researchers at the 2011 Digestive Disease Week (DDW) meeting.

“Despite the fact that these people are at very high risk for severe liver injury, they are not vaccinated at the level you would expect,” said Zobair Younossi, MD, vice president of research for Inova Health System in Falls Church, Va., and executive director of the Center for Liver Diseases at Inova Fairfax Hospital. “We must consider other ways to distribute the vaccine, perhaps having it available in gastroenterology offices and primary care physicians’ offices,” he said.

Read more.....

No comments:

Post a Comment